27.01.2022

FSN requirements for publication

The defining regulations on the presentation of field safety notices (FSN) concerning products on the Swiss market can be found under Manufacturers & authorized representatives, in the submenu Field Safety Corrective Action (FSCA), >According to MedDO (for MD).

21.01.2022

Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3

21.01.2022

DHPC – Diazepam-Mepha rectal, Mikroklisma

Wichtige sicherheitsrelevante Mitteilung

20.01.2022

Training as a specialist in pharmaceutical medicine at Swissmedic

Swissmedic certified as a category A training institution

20.01.2022

Adaptation of guidance document “Drug Signals HMP”

Change in procedure: Shortened reporting time limits for signals from foreign authorities that are classified as emerging safety issues.

19.01.2022

Important information – Spikevax, dispersion for injection

Extension of the shelf-life from 7 to 9 months for storage

18.01.2022

Pfizer submits authorisation application for Paxlovid for treatment of COVID-19

New oral medicinal product Paxlovid (active substances nirmatrelvir/ritonavir) for the treatment of COVID-19 in rolling review process

In focus

Covid-19-Fokus

COVID-19 Pandemic

Information on the new coronavirus (SARS-CoV-2)
 

Vaccines against COVID-19

20 years Swissmedic

Anniversary message from the Director

Happy Birthday Swissmedic

Contact for members of the public

Do you have any questions about a particular medicine or a general question about Swissmedic? We’ll be glad to be of assistance. 

Just send an e-mail to anfragen@swissmedic.ch or use our contact form. Thank you.

Direct links


Stay up to date


Reporting undesirable effects and incidents

Medicines


Medical devices

Swiss Public Assessment Report (SwissPAR)

SwissPAR

Public Summary SwissPAR

Featured


Medizinprodukte

27.04.2021

New medical devices regulations

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

04.12.2018

Therapeutic Products Legislation update

The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019

swissmedic-teaser-mep-video1-anim

What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.


Swissmedic, Swiss Agency for Therapeutic Products

swissmedic_hauptsitz-hallerstrasse7-bern_03

Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...
https://www.swissmedic.ch/content/swissmedic/en/home.html